Propel the next generation of cancer therapeutics with novel multiomic insights from Guardant Infinity
The first platform that combines
genomic, epigenomic,
and RNA-based fusion profiling to deliver multiomic insights
Novel, non-destructive methylation technology enabling far greater coverage and capture of tumor signal across the methylome
Guardant Infinity is for Research Use Only. Not for use in diagnostic procedures
A single technology platform
that powers our entire portfolio—building an expansive epigenomic
real-world database
InfinityAI is not a standalone customer product. “Powered by InfinityAI” refers to Guardant Health artificial intelligence and machine learning technology used in development of product features. These features are reported as professional service and have not been cleared or approved by the US FDA.
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma